Please assess the completion status of the following clinical trial:

Trial Title: Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with grade 2 to grade 4 atrophic acne scars, classified on the basis of Goodman's Qualitative classification.6~* Should not have undergone any surgical and/or laser treatment for acne scars in the past 1 year.~Exclusion Criteria:~* Active acne~* History of keloidal tendency/hypertrophic or keloidal scarring on the face due to acne~* Facial scars due to reasons other than acne like varicella, trauma, burns etc~* Collagen vascular disease, bleeding disorders~* Any active bacterial , fungal or viral infection over face~* Pregnant and lactating females~* Known hypersensitivity to tazarotene~* Age less than 18 years~* Patients on anticoagulant therapy or aspirin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tazarotene gel arm (Type: EXPERIMENTAL): The treatment protocol in this arm will consist of night time application of Tazarotene 0.1% gel during the entire study period. (3 months)
- Microneedling arm (Type: ACTIVE_COMPARATOR): The treatment protocol in this arm will consist of four sessions of microneedling at monthly intervals. (0, 1, 2, 3 months)

Based on this trial design, predict the completion outcome and termination type (if applicable).